Ailsa Rose

855 total citations
8 papers, 230 citations indexed

About

Ailsa Rose is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ailsa Rose has authored 8 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Ailsa Rose's work include Virus-based gene therapy research (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and RNA Interference and Gene Delivery (3 papers). Ailsa Rose is often cited by papers focused on Virus-based gene therapy research (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and RNA Interference and Gene Delivery (3 papers). Ailsa Rose collaborates with scholars based in United Kingdom, United States and India. Ailsa Rose's co-authors include Alan Melcher, Karen J. Scott, Richard G. Vile, R. P. Levine, Kevin J. Harrington, Matthew Coffey, Fiona Errington‐Mais, Peter J. Selby, Elizabeth J. Ilett and Lynette P. Steele and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Ailsa Rose

8 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ailsa Rose United Kingdom 6 127 88 73 62 56 8 230
Emma J. West United Kingdom 10 196 1.5× 189 2.1× 123 1.7× 40 0.6× 132 2.4× 22 360
Sarah Aref United Kingdom 4 104 0.8× 80 0.9× 63 0.9× 27 0.4× 47 0.8× 4 213
Ibrahim Ragab Eissa Japan 8 198 1.6× 190 2.2× 123 1.7× 39 0.6× 69 1.2× 12 307
Y. Schlesinger France 5 238 1.9× 129 1.5× 166 2.3× 59 1.0× 26 0.5× 10 316
Joachim Hagel United Kingdom 5 165 1.3× 213 2.4× 105 1.4× 26 0.4× 116 2.1× 6 300
Gary Keeney United States 3 127 1.0× 82 0.9× 50 0.7× 35 0.6× 26 0.5× 4 214
Tim Peterson United States 8 114 0.9× 125 1.4× 110 1.5× 29 0.5× 48 0.9× 16 292
Dongling Gao China 8 232 1.8× 257 2.9× 147 2.0× 33 0.5× 113 2.0× 22 401
Alessandro Bonetti United Kingdom 6 129 1.0× 121 1.4× 106 1.5× 16 0.3× 64 1.1× 8 251
Sergio Lavilla-Alonso Finland 9 140 1.1× 152 1.7× 132 1.8× 19 0.3× 54 1.0× 11 268

Countries citing papers authored by Ailsa Rose

Since Specialization
Citations

This map shows the geographic impact of Ailsa Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailsa Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailsa Rose more than expected).

Fields of papers citing papers by Ailsa Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailsa Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailsa Rose. The network helps show where Ailsa Rose may publish in the future.

Co-authorship network of co-authors of Ailsa Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Ailsa Rose. A scholar is included among the top collaborators of Ailsa Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailsa Rose. Ailsa Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cioccoloni, Giorgia, Hanne Røberg‐Larsen, Baek Kim, et al.. (2021). Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene. 40(16). 2872–2883. 26 indexed citations
2.
Cockle, Julia, Anke Brüning‐Richardson, Karen J. Scott, et al.. (2017). Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion. Molecular Therapy — Oncolytics. 5. 75–86. 23 indexed citations
3.
Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). P12 * A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(R) IN PATIENTS WITH BRAIN TUMOURS. Neuro-Oncology. 16(suppl 6). vi3–vi3. 2 indexed citations
4.
Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). Oncolytic wild-type reovirus infection in brain tumors following intravenous administration in patients.. Journal of Clinical Oncology. 32(15_suppl). 3104–3104. 3 indexed citations
5.
Nuovo, Gerard J., Michela Garofalo, Nicola Valeri, et al.. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Modern Pathology. 25(10). 1333–1344. 45 indexed citations
6.
Hall, Kathryn, Karen J. Scott, Ailsa Rose, et al.. (2012). Reovirus-Mediated Cytotoxicity and Enhancement of Innate Immune Responses Against Acute Myeloid Leukemia. SHILAP Revista de lepidopterología. 1(1). 3–15. 22 indexed citations
7.
Errington‐Mais, Fiona, Charles L. White, Katie Twigger, et al.. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Therapy. 15(18). 1257–1270. 86 indexed citations
8.
Rose, Ailsa & R. P. Levine. (1992). Complement-mediated opsonisation and phagocytosis of Renibacterium salmoninarum. Fish & Shellfish Immunology. 2(3). 223–240. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026